Key Financial Data Of Group

Carna Biosciences, Inc. - Filing #7568781

Concept 2023-01-01 to
2023-03-31
As at
2023-03-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-03-31
As at
2022-03-31
Key financial data of group
Business results of group
Net sales
226,967,000 JPY
1,386,748,000 JPY
554,650,000 JPY
Ordinary profit (loss)
-513,368,000 JPY
-1,278,820,000 JPY
4,576,000 JPY
Profit (loss) attributable to owners of parent
-519,210,000 JPY
-1,349,539,000 JPY
-15,104,000 JPY
Comprehensive income
-518,278,000 JPY
-1,331,861,000 JPY
31,390,000 JPY
Net assets
4,397,841,000 JPY
3,641,844,000 JPY
4,540,757,000 JPY
Total assets
4,945,261,000 JPY
4,266,453,000 JPY
5,355,256,000 JPY
Basic earnings (loss) per share
-32.78
-99.10
-1.12
Diluted earnings per share
Equity-to-asset ratio
0.888 xbrli:pure
0.850 xbrli:pure
0.846 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.